Key Dates

Related Announcements

PA-20-190 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

PA-20-176 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)

NOT-DK-21-019 - Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

Under normal circumstances, individuals applying to the NIH Mentored Research Scientist Development Award (K01) with a project within the mission interests of the NIDDK must have no more than 7 years of post-doctoral research experience. The purpose of this Notice is to inform the extramural community that due to ongoing disruptions caused by the COVID-19 pandemic, the NIDDK will provide a one-receipt cycle extension (roughly four additional months) of eligibility for prospective applicants meeting the requirements for submission of a K01 application from the period covered by the February/March 2022 and June/July 2022 due dates. Such individuals will be permitted to submit applications up to the June/July 2022 and October/November 2022 due dates, respectively. This extension applies to AIDS as well as non AIDS dates.

Individuals who have previously received a two-receipt cycle extension as described in NOT-DK-21-019: Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic are not eligible for an additional extension. Additionally, multiple extensions for events occurring during the same time period (e.g. childbirth during the COVID pandemic) will not be permitted. Prospective K01 candidates may only receive an extension for one category for events that occurred within overlapping time periods.

Implementation

The one-receipt cycle extension in eligibility under this Notice applies only to applicants for a K01 award under one of the following Funding Opportunity Announcements: PA-20-176: Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) and PA-20-190: Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed).

For eligible applicants submitting new or resubmission applications, the one-receipt cycle extension will be automatically accepted by the NIH; no additional documentation is required.

To aid potential applicants in determining whether they are eligible for the extension, the following examples are provided:

Example 1: For individuals whose eligibility ended with October/November 2021 due dates, the temporary extension permitted in NOT-DK-21-019 allowed them to apply for the K01 in February/March 2022 or June/July 2022. They are not eligible for an additional one cycle extension to October/November 2022.

Example 2: For individuals whose eligibility ended with February/March 2022 due dates, the temporary extension allows them to apply for the K01 in June/July 2022.

Example 3: For individuals whose eligibility ends with the June/July 2022 due dates, the temporary extension would allow them to apply for the K01 in October/November 2022.

This policy may be subject to future updates.

Inquiries

Please direct all inquiries to:

Lisa M. Spain, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-541-9871
Email: spainl@nih.gov